A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James Burke, MD
Jennerex Biotherapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alberta
Edmonton, Alberta, Canada
- University of British Columbia
Vancouver, British Columbia, Canada
- Juravinski Cancer Centre
Hamilton, Ontario, Canada
- Ottawa Hopsital Research Institute
Ottawa, Ontario, Canada
- Hôpitaux Universitaires de Strasbourg - Hôpital Civil
Strasbourg, Alsace, France
- Centre Hospitalier Universitaire Hôpital Saint André
Bordeaux, Aquitaine, France
- Chu D'Estaing
Clermont-Ferrand, Auvergne, France
- Hôpital de la Croix Rousse
Lyon, Auvergne-Rhône-Alpes, France
- Hôpital Purpan
Toulouse, Midi-Pyrenees, France
- Hôpital Saint Antoine, Cpp Ile de France V
Paris, Île-de-France Region, France
- Klinikum Rechts Der Isar Der Technischen Universität München
München, Bavaria, Germany
- Medizinische Hochschule Hannover
Hanover, Lower Saxony, Germany
- Johannes Gutenberg-Universität Mainz
Mainz, Rhineland-Palatinate, Germany
- Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
- Queen Mary Hospital
Hong Kong, Hong Kong
- Korea University Ansan Hospital
Ansan-si, Gyeonggi-do, South Korea
- Kyungpook National University Hospital
Daegu, South Korea
- Pusan National University Hospital
Pusan, South Korea
- Asan Medical Center
Seoul, South Korea
- Korea University Guro Hospital
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Severance Hospital,yonsei University Health System
Seoul, South Korea
- Pusan National University Yangsan Hospital
Yangsan, South Korea
- National Cheng-Kung University Hospital
Tainan, Taiwan
- National Taiwan University Hospital
Taipei, Taiwan
- Taipei Veterans General Hospital
Taipei, Taiwan
- Moores University of California San Diego Cancer Center
La Jolla, California, United States
- Chao Family Comprehensive Cancer Center
Orange, California, United States
- California Pacific Medical Center
San Francisco, California, United States
- Stanford Hospital and Clinics
Stanford, California, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Billings Clinic
Billings, Montana, United States
- Saint Joseph'S Hospital
Paterson, New Jersey, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- University Hospitals Case Medical Center
Cleveland, Ohio, United States
- the Methodist Hospital Department of Surgery
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Oct 2011
- Primary completion
- 1 Oct 2013
- Completion
- 1 Oct 2013
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 129
- Registry id
- NCT01387555
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.